Profusa, Inc. Files 8-K on Delisting Concerns
Ticker: NVACW · Form: 8-K · Filed: Sep 16, 2025 · CIK: 1859807
| Field | Detail |
|---|---|
| Company | Profusa, INC. (NVACW) |
| Form Type | 8-K |
| Filed Date | Sep 16, 2025 |
| Risk Level | high |
| Pages | 4 |
| Reading Time | 5 min |
| Key Dollar Amounts | $0.0001, $50,000,000, $1.00 |
| Sentiment | bearish |
Sentiment: bearish
Topics: delisting, listing-standards, regulatory
TL;DR
Profusa's in danger of being delisted, filing shows.
AI Summary
Profusa, Inc. filed an 8-K on September 16, 2025, reporting a notice of delisting or failure to satisfy continued listing rules. The filing also includes financial statements and exhibits. Profusa, Inc. was formerly known as NorthView Acquisition Corp until April 29, 2021.
Why It Matters
This filing indicates potential issues with Profusa, Inc.'s continued listing on an exchange, which could impact its stock value and investor confidence.
Risk Assessment
Risk Level: high — A notice of delisting or failure to meet listing standards suggests significant financial or operational distress for the company.
Key Players & Entities
- Profusa, Inc. (company) — Registrant
- NorthView Acquisition Corp (company) — Former company name
- 20210429 (date) — Date of name change
- September 11, 2025 (date) — Earliest event reported date
- September 16, 2025 (date) — Filing date
FAQ
What specific listing rule or standard has Profusa, Inc. failed to satisfy?
The filing indicates a 'Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard' but does not specify the exact rule or standard in the provided text.
What are the implications of this delisting notice for Profusa, Inc.'s stock?
A delisting notice typically raises concerns about the company's financial health and can lead to a decrease in stock value and liquidity.
When was Profusa, Inc. previously known as NorthView Acquisition Corp?
Profusa, Inc. was formerly known as NorthView Acquisition Corp until April 29, 2021.
What is the primary business of Profusa, Inc. based on its SIC code?
Profusa, Inc. is classified under SIC code 3841, which pertains to 'Surgical & Medical Instruments & Apparatus'.
What is the principal executive office address for Profusa, Inc.?
The principal executive offices of Profusa, Inc. are located at 626 Bancroft Way, Suite A, Berkeley, CA 94710.
Filing Stats: 1,182 words · 5 min read · ~4 pages · Grade level 15.4 · Accepted 2025-09-16 17:20:25
Key Financial Figures
- $0.0001 — ch registered Common Stock, par value $0.0001 per share PFSA The Nasdaq Stock Mar
- $50,000,000 — al Market to maintain a minimum MVLS of $50,000,000. Pursuant to Nasdaq Listing Rule 5810(
- $1.00 — rket to maintain a minimum bid price of $1.00 per share. Pursuant to Nasdaq Listing
Filing Documents
- ea0257626-8k_profusa.htm (8-K) — 29KB
- 0001213900-25-088253.txt ( ) — 193KB
- pfsa-20250911.xsd (EX-101.SCH) — 3KB
- pfsa-20250911_lab.xml (EX-101.LAB) — 33KB
- pfsa-20250911_pre.xml (EX-101.PRE) — 22KB
- ea0257626-8k_profusa_htm.xml (XML) — 4KB
01 Notice of Delisting or Failure to
Item 3.01 Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing. On September 11, 2025, Profusa, Inc. (the " Company ") received a notice (the " MVLS Notice ") from the Listing Qualifications Department of The Nasdaq Stock Market LLC (" Nasdaq ") notifying the Company that, based upon its review of the market value of listed securities (" MVLS ") of the Company's common stock, par value $0.0001 per share (the " Common Stock "), from July 29, 2025 to September 10, 2025, the Company no longer meets Nasdaq Listing Rule 5450(b)(2)(A), which requires companies listed on the Nasdaq Global Market to maintain a minimum MVLS of $50,000,000. Pursuant to Nasdaq Listing Rule 5810(c)(3)(C), the Company has been provided a compliance period of 180 calendar days, or until March 10, 2026, to regain compliance with Nasdaq Listing Rule 5450(b)(2)(A). If at any time during this compliance period, the Common Stock's MVLS closes at $50,000,000 or more for a minimum of ten consecutive business days, Nasdaq will provide the Company with written confirmation of compliance and this matter will be closed, provided, however that Nasdaq may, in its discretion, require the Company to maintain the minimum MVLS for a period in excess of ten consecutive business days, but generally no more than 20 consecutive business days, before determining that the Company has demonstrated an ability to maintain long-term compliance. In the event the Company does not regain compliance with Nasdaq Listing Rule 5450(b)(2)(A) prior to the expiration of the compliance period, the Company will receive written notification that the Company's securities are subject to delisting. At that time, the Company may appeal the delisting determination to a hearings panel. Alternatively, the Company may consider applying to transfer the listing of the Company's securities to the Nasdaq Capital Market, provided that the Company then satisfies the requirements for continued listin
01 Financial Statements and Exhibits
Item 9.01 Financial Statements and Exhibits. (d) Exhibits EXHIBIT INDEX Exhibit No. Description 104 Cover Page Interactive Data File (embedded within the Inline XBRL document) 1 SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Dated: September 16, 2025 Profusa, Inc. By: /s/ Ben Hwang Name: Ben Hwang Title: Chief Executive Officer 2